Status:
RECRUITING
The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction
Lead Sponsor:
University Hospital, Angers
Conditions:
Cesarean Section; Dehiscence
Eligibility:
FEMALE
18-43 years
Brief Summary
The prevalence of Caesarean sections continues to increase around the world. In France, the proportion of Caesarean sections has doubled from 11% in 1981 to 20,2% in 2016, bringing with it an increase...
Detailed Description
The study has a multicentric, parallel group, comparative, non-interventional, exploratory and prospective design. Definition of isthmocele: defined as a dehiscence of the hysterotomy following a cae...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Patients with a history of at least one cesarean section (single or multi-scarred uterus).
- Age between 18 and 43 years old
- Secondary infertility requiring ART techniques (FIV or FIV ICSI).
- A Hysterosonography examination as part of the pre-ART assessment allowing for the detection of the presence of an isthmocele.
- French speaking patients
- Patient affiliated to or beneficiary of a social security scheme
- Non-inclusion criteria :
- \- Refusal to participate in the study.
Exclusion
Key Trial Info
Start Date :
May 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04869007
Start Date
May 30 2022
End Date
November 30 2026
Last Update
July 23 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Angers
Angers, France, 49933
2
University Hospital of Brest
Brest, France
3
Hospital Center Sud Francilien
Corbeil-Essonnes, France
4
Creteil University Hospital
Créteil, France